AXIM Biotechnologies, Inc. financial statements
AXIM Biotechnologies, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2023
| Revenue | USD 39.52K | 10-K |
| Net income | −USD 8.06M | 10-K |
| Cash and equivalents | USD 156.46K | 10-Q |
| Total debt | USD 4.89M | 10-Q |
AXIM Biotechnologies, Inc. financials on 6ix · AXIM Biotechnologies, Inc. on 6ix